Cover Image
市場調查報告書

全球移植用組織相容抗原檢查市場各技術,各產品規模,產業分析報告,各地區預測,潛在性用途,價格趨勢,競爭市場佔有率,未來預測

HLA Typing for Transplant Market Size By Technology, By Product and Services, By Application, By End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024

出版商 Global Market Insights Inc. 商品編碼 605710
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球移植用組織相容抗原檢查市場各技術,各產品規模,產業分析報告,各地區預測,潛在性用途,價格趨勢,競爭市場佔有率,未來預測 HLA Typing for Transplant Market Size By Technology, By Product and Services, By Application, By End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024
出版日期: 2018年01月10日 內容資訊: 英文 185 Pages
簡介

本報告提供全球移植用組織相容抗原檢查市場相關調查,彙整市場概要和各市場區隔,各地區趨勢,及加入此市場的主要企業簡介等資料。

第1章 調查方法

第2章 摘要整理

第3章 產業趨勢

  • 產業市場區隔
  • 產業環境
  • 產業影響因素
    • 促進成長要素
    • 陷阱與課題
  • 成長可能性分析
  • 法律制度
  • 波特五力分析
  • 競爭環境
  • PESTEL分析

第4章 各技術市場

  • 市場佔有率
  • 非分子化驗
  • 分子化驗

第5章 產品與服務市場

  • 市場佔有率
  • 計量儀器
  • 試劑·消耗品
  • 軟體
  • 服務

第6章 各用途市場

  • 市場佔有率
  • 診斷
  • 研究

第7章 各最終用途市場

  • 市場佔有率
  • 醫院
  • 學術研究機關

第8章 各地區市場

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 企業簡介

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Bio-Reference Laboratories
  • CareDx, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GenDx
  • Illumina Inc.
  • Immucor Inc.
  • Inno-train Diagnostik GmbH
  • Luminex Corporation
  • Omixon Inc.
  • Pacific Biosciences of California, Inc.
  • Qiagen
  • Thermo Fischer Scientific (Linkage Biosciences)

圖表

目錄
Product Code: 1653

HLA Typing for Transplant Marketto exceed USD 720 million by 2024; according to a new research report.

Increasing number of solid organ transplants will fuel industry growth over the forecast timeframe. Growing patient pool suffering from terminal and irreversible organ failure is leading to a surge in solid organ transplant demand. Growing geriatric population will further augment growth as the elderly individuals have a higher susceptibility towards various chronic disorders owing to anatomic and functional changes along with impairment of immune system.

Technological advancements will further aid industry expansion. The industry participants are focusing on developing technologies which substantially improve allele resolution. However, presence of significant gap between number of organs donated and organs required for transplant procedures hinders industry growth. Higher cost of molecular assays used for HLA typing is another barrier hampering adoption rates.

Molecular assays held significant industry share in 2016. Growing demand for molecular tests in HLA typing owing to its ability to provide more accurate results in less time as compared to non-molecular assays will propel segment growth over the forecast timeframe.

Sequencing based molecular assays are poised to witness fastest growth as the technology provides the capability of generating a large amount of clonal sequences in a single sequencing run.

Reagents and consumables segment will grow at a robust rate owing to their requirement in larger quantities and higher frequency of use in HLA typing procedures.

Application of HLA typing for transplant in research held considerable industry share in 2016. Increasing research and development activities focused on developing advanced and rapid methods with higher accuracy will further boost segment growth.

Hospitals segment is poised to witness rapid growth owing to increasing number of patients undergoing organ transplant procedures in these settings.

UK HLA typing for transplant market is poised to witness lucrative growth owing to increasing number of bone marrow donors. Furthermore, adoption of strategies such as 'taking organ transplantation to 2020' which aims to increase the authorization rate from 57 percent in 2012/2013 to over 80 percent in 2020 will augment industry expansion.

South Africa HLA typing for transplant market presents a lucrative future opportunity due to the presence of a large patient population base requiring organ transplants. Growing awareness pertaining to the need and importance of organ donation will further fuel demand.

Prominent industry participants include Thermo Fischer Scientific, CareDx, GenDx, Pacific Biosciences, Immucor and Illumina. The industry players adopt various strategies such as partnerships and collaborations, new product launch, distributor agreements and acquisition for strengthening their industry presence. For instance, in April 2016, CareDx acquired Allenex AB. The acquisition has enhanced the company's position in the HLA typing for transplant industry.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
    • 1.1.1 Initial data exploration
    • 1.1.2 Statistical model and forecast
    • 1.1.3 Industry insights and validation
    • 1.1.4 Market definitions
  • 1.2 Data Sources
    • 1.2.1 Secondary
    • 1.2.2 Primary

Chapter 2 Executive Summary

  • 2.1 HLA typing for transplant industry 360 degree synopsis, 2013 - 2024
    • 2.1.1 Business trends
    • 2.1.2 Technology trends
    • 2.1.3 Product and services trends
    • 2.1.4 Application trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 HLA Typing for Transplant Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2013- 2024
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing number of solid organ transplants
    • 3.3.1.2 Technological advancements
    • 3.3.1.3 Increasing geriatric population
    • 3.3.2 Industry pitfalls and challenges
    • 3.3.2.1 Significant gap between number of organs donated and organs required
    • 3.3.2.2 High costs of molecular tests
  • 3.4 Growth potential analysis
    • 3.4.1 By, technology
    • 3.4.2 By, product and services
    • 3.4.3 By, application
    • 3.4.4 By, end-use
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape
    • 3.7.1 Strategic dashboard
  • 3.8 PESTEL analysis

Chapter 4 HLA Typing for Transplant Market, By Technology

  • 4.1 HLA typing for transplant market share by technology, 2016 & 2024
  • 4.2 Non-Molecular assays
    • 4.2.1 Market estimates and forecast, by region, 2013 - 2024
    • 4.2.2 Serological assays
    • 4.2.2.1 Market estimates and forecast, by region, 2013 - 2024
    • 4.2.3 Mixed lymphocyte culture assay
    • 4.2.3.1 Market estimates and forecast, by region, 2013 - 2024
  • 4.3 Molecular assays
    • 4.3.1 Market estimates and forecast, by region, 2013 - 2024
    • 4.3.2 PCR based molecular assays
    • 4.3.2.1 Market estimates and forecast, by region, 2013 - 2024
    • 4.3.3 Sequencing based molecular assays
    • 4.3.3.1 Market estimates and forecast, by region, 2013 - 2024
    • 4.3.3.2 Sanger sequencing
        • 4.3.3.2.1 Market estimates and forecast, by region, 2013 - 2024
    • 4.3.3.3 Next generation sequencing
        • 4.3.3.3.1 Market estimates and forecast, by region, 2013 - 2024

Chapter 5 HLA Typing for Transplant Market, By Product and Services

  • 5.1 HLA typing for transplant market share by product and services, 2016 & 2024
  • 5.2 Instruments
    • 5.2.1 Market estimates and forecast, by region, 2013 - 2024
  • 5.3 Reagents and consumables
    • 5.3.1 Market estimates and forecast, by region, 2013 - 2024
  • 5.4 Software
    • 5.4.1 Market estimates and forecast, by region, 2013 - 2024
  • 5.5 Services
    • 5.5.1 Market estimates and forecast, by region, 2013 - 2024

Chapter 6 HLA Typing for Transplant Market, By Application

  • 6.1 HLA typing for transplant market share by application, 2016 & 2024
  • 6.2 Diagnostics
    • 6.2.1 Market size by region, 2013 - 2024
  • 6.3 Research
    • 6.3.1 Market size by region, 2013 - 2024

Chapter 7 HLA Typing for Transplant Market, By End-Use

  • 7.1 HLA typing for transplant market share by end-use, 2016 & 2024
  • 7.2 Hospitals
    • 7.2.1 Market estimates and forecast, by region, 2013-2024
  • 7.3 Academic and research institutes
    • 7.3.1 Market estimates and forecast, by region, 2013-2024

Chapter 8 HLA typing for transplant Market, By Region

  • 8.1 HLA typing for transplant market share by region, 2016 & 2024
  • 8.2 North America
    • 8.2.1 Market size, by country, 2013 - 2024
    • 8.2.2 Market size, by technology, 2013 - 2024
    • 8.2.2.1 Market size, by non-molecular, 2013 - 2024
    • 8.2.2.2 Market size, by molecular Assays, 2013 - 2024
        • 8.2.2.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.2.3 Market size, by product and services, 2013 - 2024
    • 8.2.4 Market size, by application, 2013 - 2024
    • 8.2.5 Market size, by end-use, 2013 - 2024
    • 8.2.6 U.S.
    • 8.2.6.1 Market size, by technology, 2013 - 2024
        • 8.2.6.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.2.6.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.2.6.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.2.6.2 Market size, by product and services, 2013 - 2024
    • 8.2.6.3 Market size, by application, 2013 - 2024
    • 8.2.6.4 Market size, by end-use, 2013 - 2024
    • 8.2.7 Canada
    • 8.2.7.1 Market size, by technology, 2013 - 2024
        • 8.2.7.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.2.7.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.2.7.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.2.7.2 Market size, by product and services, 2013 - 2024
    • 8.2.7.3 Market size, by application, 2013 - 2024
    • 8.2.7.4 Market size, by end-use, 2013 - 2024
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2013 - 2024
    • 8.3.2 Market size, by technology, 2013 - 2024
    • 8.3.2.1 Market size, by non-molecular, 2013 - 2024
    • 8.3.2.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.2.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.3 Market size, by product and services, 2013 - 2024
    • 8.3.4 Market size, by application, 2013 - 2024
    • 8.3.5 Market size, by end-use, 2013 - 2024
    • 8.3.6 Germany
    • 8.3.6.1 Market size, by technology, 2013 - 2024
        • 8.3.6.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.3.6.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.6.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.6.2 Market size, by product and services, 2013 - 2024
    • 8.3.6.3 Market size, by application, 2013 - 2024
    • 8.3.6.4 Market size, by end-use, 2013 - 2024
    • 8.3.7 UK
    • 8.3.7.1 Market size, by technology, 2013 - 2024
        • 8.3.7.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.3.7.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.7.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.7.2 Market size, by product and services, 2013 - 2024
    • 8.3.7.3 Market size, by application, 2013 - 2024
    • 8.3.7.4 Market size, by end-use, 2013 - 2024
    • 8.3.8 France
    • 8.3.8.1 Market size, by technology, 2013 - 2024
        • 8.3.8.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.3.8.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.8.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.8.2 Market size, by product and services, 2013 - 2024
    • 8.3.8.3 Market size, by application, 2013 - 2024
    • 8.3.8.4 Market size, by end-use, 2013 - 2024
    • 8.3.9 Italy
    • 8.3.9.1 Market size, by technology, 2013 - 2024
        • 8.3.9.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.3.9.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.9.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.9.2 Market size, by product and services, 2013 - 2024
    • 8.3.9.3 Market size, by application, 2013 - 2024
    • 8.3.9.4 Market size, by end-use, 2013 - 2024
    • 8.3.10 Spain
    • 8.3.10.1 Market size, by technology, 2013 - 2024
        • 8.3.10.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.3.10.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.10.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.10.2 Market size, by product and services, 2013 - 2024
    • 8.3.10.3 Market size, by application, 2013 - 2024
    • 8.3.10.4 Market size, by end-use, 2013 - 2024
    • 8.3.11 Russia
    • 8.3.11.1 Market size, by technology, 2013 - 2024
        • 8.3.11.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.3.11.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.3.11.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.3.11.2 Market size, by product and services, 2013 - 2024
    • 8.3.11.3 Market size, by application, 2013 - 2024
    • 8.3.11.4 Market size, by end-use, 2013 - 2024
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2013 - 2024
    • 8.4.2 Market size, by technology, 2013 - 2024
    • 8.4.2.1 Market size, by non-molecular, 2013 - 2024
    • 8.4.2.2 Market size, by molecular assays, 2013 - 2024
        • 8.4.2.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.4.3 Market size, by product and services, 2013 - 2024
    • 8.4.4 Market size, by application, 2013 - 2024
    • 8.4.5 Market size, by end-use, 2013 - 2024
    • 8.4.6 China
    • 8.4.6.1 Market size, by technology, 2013 - 2024
        • 8.4.6.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.4.6.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.4.6.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.4.6.2 Market size, by product and services, 2013 - 2024
    • 8.4.6.3 Market size, by application, 2013 - 2024
    • 8.4.6.4 Market size, by end-use, 2013 - 2024
    • 8.4.7 India
    • 8.4.7.1 Market size, by technology, 2013 - 2024
        • 8.4.7.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.4.7.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.4.7.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.4.7.2 Market size, by product and services, 2013 - 2024
    • 8.4.7.3 Market size, by application, 2013 - 2024
    • 8.4.7.4 Market size, by end-use, 2013 - 2024
    • 8.4.8 Japan
    • 8.4.8.1 Market size, by technology, 2013 - 2024
        • 8.4.8.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.4.8.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.4.8.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.4.8.2 Market size, by product and services, 2013 - 2024
    • 8.4.8.3 Market size, by application, 2013 - 2024
    • 8.4.8.4 Market size, by end-use, 2013 - 2024
    • 8.4.9 Australia
    • 8.4.9.1 Market size, by technology, 2013 - 2024
        • 8.4.9.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.4.9.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.4.9.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.4.9.2 Market size, by product and services, 2013 - 2024
    • 8.4.9.3 Market size, by application, 2013 - 2024
    • 8.4.9.4 Market size, by end-use, 2013 - 2024
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2013 - 2024
    • 8.5.2 Market size, by technology, 2013 - 2024
    • 8.5.2.1 Market size, by non-molecular, 2013 - 2024
    • 8.5.2.2 Market size, by molecular assays, 2013 - 2024
        • 8.5.2.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.5.3 Market size, by product and services, 2013 - 2024
    • 8.5.4 Market size, by application, 2013 - 2024
    • 8.5.5 Market size, by end-use, 2013 - 2024
    • 8.5.6 Brazil 119
    • 8.5.6.1 Market size, by technology, 2013 - 2024
        • 8.5.6.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.5.6.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.5.6.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.5.6.2 Market size, by product and services, 2013 - 2024
    • 8.5.6.3 Market size, by application, 2013 - 2024
    • 8.5.6.4 Market size, by end-use, 2013 - 2024
    • 8.5.7 Mexico
    • 8.5.7.1 Market size, by technology, 2013 - 2024
        • 8.5.7.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.5.7.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.5.7.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.5.7.2 Market size, by product and services, 2013 - 2024
    • 8.5.7.3 Market size, by application, 2013 - 2024
    • 8.5.7.4 Market size, by end-use, 2013 - 2024
  • 8.6 MEA
    • 8.6.1 Market size, by country, 2013 - 2024
    • 8.6.2 Market size, by technology, 2013 - 2024
    • 8.6.2.1 Market size, by non-molecular, 2013 - 2024
    • 8.6.2.2 Market size, by molecular assays, 2013 - 2024
        • 8.6.2.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.6.3 Market size, by product and services, 2013 - 2024
    • 8.6.4 Market size, by application, 2013 - 2024
    • 8.6.5 Market size, by end-use, 2013 - 2024
    • 8.6.6 South Africa
    • 8.6.6.1 Market size, by technology, 2013 - 2024
        • 8.6.6.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.6.6.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.6.6.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.6.6.2 Market size, by product and services, 2013 - 2024
    • 8.6.6.3 Market size, by application, 2013 - 2024
    • 8.6.6.4 Market size, by end-use, 2013 - 2024
    • 8.6.7
    • 8.6.7.1 Market size, by technology, 2013 - 2024
        • 8.6.7.1.1 Market size, by non-molecular, 2013 - 2024
        • 8.6.7.1.2 Market size, by molecular assays, 2013 - 2024
        • 8.6.7.1.2.1 Market size, sequencing based molecular assays, 2013 - 2024
    • 8.6.7.2 Market size, by product and services, 2013 - 2024
    • 8.6.7.3 Market size, by application, 2013 - 2024
    • 8.6.7.4 Market size, by end-use, 2013 - 2024

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Business overview
    • 9.1.2 Financial data
    • 9.1.3 Product landscape
    • 9.1.4 Strategic outlook
    • 9.1.5 SWOT analysis
  • 9.2 Bio-Rad Laboratories
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Bio-Reference Laboratories
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 CareDx, Inc.
    • 9.4.1 Business overview
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 F. Hoffmann-La Roche Ltd.
    • 9.5.1 Business overview
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 GenDx
    • 9.6.1 Business overview
    • 9.6.2 Product landscape
    • 9.6.3 Strategic outlook
    • 9.6.4 SWOT analysis
  • 9.7 Illumina Inc.
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 Immucor Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Inno-train Diagnostik GmbH
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 SWOT analysis
  • 9.10 Luminex Corporation
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 SWOT analysis
  • 9.11 Omixon Inc.
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 Pacific Biosciences of California, Inc.
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 Qiagen
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis
  • 9.14 Thermo Fischer Scientific (Linkage Biosciences)
    • 9.14.1 Business overview
    • 9.14.2 Financial data
    • 9.14.3 Product landscape
    • 9.14.4 Strategic outlook
    • 9.14.5 SWOT analysis

Data Tables

  • TABLE 1. HLA typing for transplant industry 360 degree synopsis, 2013 - 2024
  • TABLE 2. Global HLA typing for transplant market, 2013-2024 (USD Million)
  • TABLE 3. Global HLA typing for transplant market, by technology, 2013-2024 (USD Million)
  • TABLE 4. Global HLA typing for transplant market, by product and services, 2013-2024 (USD Million)
  • TABLE 5. Global HLA typing for transplant market, by application, 2013-2024 (USD Million)
  • TABLE 6. Global HLA typing for transplant market, by end-use, 2013-2024 (USD Million)
  • TABLE 7. Global HLA typing for transplant market, by region, 2013-2024 (USD Million)
  • TABLE 8. Non-Molecular assays market, by region, 2013 - 2024 (USD Million)
  • TABLE 9. Serological assays market, by region, 2013 - 2024 (USD Million)
  • TABLE 10. Mixed lymphocyte culture assay market, by region, 2013 - 2024 (USD Million)
  • TABLE 11. Molecular assays market, by region, 2013 - 2024 (USD Million)
  • TABLE 12. PCR based molecular assays market, by region, 2013 - 2024 (USD Million)
  • TABLE 13. Sequencing based molecular assays market, by region, 2013 - 2024 (USD Million)
  • TABLE 14. Sanger Sequencing market, by region, 2013 - 2024 (USD Million)
  • TABLE 15. Next generation sequencing market, by region, 2013 - 2024 (USD Million)
  • TABLE 16. Instruments market, by region, 2013 - 2024 (USD Million)
  • TABLE 17. Reagents and consumables market, by region, 2013 - 2024 (USD Million)
  • TABLE 18. Software market, by region, 2013 - 2024 (USD Million)
  • TABLE 19. Services market, by region, 2013 - 2024 (USD Million)
  • TABLE 20. Diagnostics market by region, 2013 - 2024 (USD Million)
  • TABLE 21. Research market by region, 2013 - 2024 (USD Million)
  • TABLE 22. Hospitals market, by region, 2013-2024 (USD Million)
  • TABLE 23. Academic and research institutes market, by region, 2013-2024 (USD Million)
  • TABLE 24. North America HLA typing for transplant market, by country, 2013 - 2024 (USD Million)
  • TABLE 25. North America HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 26. North America HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 27. North America HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 28. North America HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 29. North America HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 30. North America HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 31. North America market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 32. U.S. HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 33. U.S. HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 34. U.S. HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 35. U.S. HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 36. U.S. HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 37. U.S. HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 38. U.S. market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 39. Canada HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 40. Canada HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 41. Canada HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 42. Canada HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 43. Canada HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 44. Canada HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 45. Canada market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 46. Europe HLA typing for transplant market, by country, 2013 - 2024 (USD Million)
  • TABLE 47. Europe HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 48. Europe HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 49. Europe HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 50. Europe HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 51. Europe HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 52. Europe HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 53. Europe market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 54. Germany HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 55. Germany HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 56. Germany HLA typing for transplant market, by molecular Assays, 2013 - 2024 (USD Million)
  • TABLE 57. Germany HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 58. Germany HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 59. Germany HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 60. Germany market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 61. UK HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 62. UK HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 63. UK HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 64. UK HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 65. UK HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 66. UK HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 67. UK market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 68. France HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 69. France HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 70. France HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 71. France HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 72. France HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 73. France HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 74. France market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 75. Italy HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 76. Italy HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 77. Italy HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 78. Italy HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 79. Italy HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 80. Italy HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 81. Italy market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 82. Spain HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 83. Spain HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 84. Spain HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 85. Spain HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 86. Spain HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 87. Spain HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 88. Spain market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 89. Russia HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 90. Russia HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 91. Russia HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 92. Russia HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 93. Russia HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 94. Russia HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 95. Russia market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 96. Asia Pacific HLA typing for transplant market, by country, 2013 - 2024 (USD Million)
  • TABLE 97. Asia Pacific HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 98. Asia Pacific HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 99. Asia Pacific HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 100. Asia Pacific HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 101. Asia Pacific HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 102. Asia Pacific HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 103. Asia Pacific market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 104. China HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 105. China HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 106. China HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 107. China HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 108. China HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 109. China HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 110. China market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 111. India HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 112. India HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 113. India HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 114. India HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 115. India HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 116. India HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 117. India market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 118. Japan HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 119. Japan HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 120. Japan HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 121. Japan HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 122. Japan HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 123. Japan HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 124. Japan market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 125. Australia HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 126. Australia HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 127. Australia HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 128. Australia HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 129. Australia HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 130. Australia HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 131. Australia market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 132. Latin America HLA typing for transplant market, by country, 2013 - 2024 (USD Million)
  • TABLE 133. Latin America HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 134. Latin America HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 135. Latin America HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 136. Latin America HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 137. Latin America HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 138. Latin America HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 139. Latin America market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 140. Number of transplants performed in Brazil in 2012 and 2014
  • TABLE 141. Brazil HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 142. Brazil HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 143. Brazil HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 144. Brazil HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 145. Brazil HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 146. Brazil HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 147. Brazil market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 148. Mexico HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 149. Mexico HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 150. Mexico HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 151. Mexico HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 152. Mexico HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 153. Mexico HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 154. Mexico market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 155. MEA HLA typing for transplant market, by country, 2013 - 2024 (USD Million)
  • TABLE 156. MEA HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 157. MEA HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 158. MEA HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 159. MEA HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 160. MEA HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 161. MEA HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 162. MEA market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 163. South Africa HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 164. South Africa HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 165. South Africa HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 166. South Africa HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 167. South Africa HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 168. South Africa HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 169. South Africa market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 170. Saudi Arabia HLA typing for transplant market, by technology, 2013 - 2024 (USD Million)
  • TABLE 171. Saudi Arabia HLA typing for transplant market, by non-molecular, 2013 - 2024 (USD Million)
  • TABLE 172. Saudi Arabia HLA typing for transplant market, by molecular assays, 2013 - 2024 (USD Million)
  • TABLE 173. Saudi Arabia HLA typing for transplant market, by sequencing based molecular assays, 2013 - 2024 (USD Million)
  • TABLE 174. Saudi Arabia HLA typing for transplant market, by product and services, 2013 - 2024 (USD Million)
  • TABLE 175. Saudi Arabia HLA typing for transplant market, by application, 2013 - 2024 (USD Million)
  • TABLE 176. Saudi Arabia HLA typing for transplant market, by end-use, 2013 - 2024 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global HLA typing for transplant market, 2013 - 2024 (USD Million)
  • FIG. 3 Organs transplants in 2016
  • FIG. 4 Donors, organ transplants and transplant waiting list (UK)
  • FIG. 5 Organs patients are waiting for in U.S. (2017)
  • FIG. 6 Growth potential analysis, by technology
  • FIG. 7 Growth potential analysis, by product and services
  • FIG. 8 Growth potential analysis, by application
  • FIG. 9 Growth potential analysis, by end-use
  • FIG. 10 Porter's Analysis
  • FIG. 11 Strategic Dashboard
  • FIG. 12 PESTEL Analysis
  • FIG. 13 HLA typing for transplant market share by technology, 2016 & 2024
  • FIG. 14 HLA typing for transplant market share by product and services, 2016 & 2024
  • FIG. 15 HLA typing for transplant market share by application, 2016 & 2024
  • FIG. 16 HLA typing for transplant market share by end-use, 2016 & 2024
  • FIG. 17 HLA typing for transplant market share, by region, 2016 & 2024
  • FIG. 18 Number of transplants performed (in thousands) in U.S. from 2012 to 2016
Back to Top